Related references
Note: Only part of the references are listed.Mast Cells in Neurodegenerative Disease
Michael K. Jones et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2019)
Lessons Learned from Alzheimer Disease: Clinical Trials with Negative Outcomes
Jeffrey Cummings
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2018)
Distinct inflammatory phenotypes of microglia and monocyte-derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology
Elodie Martin et al.
AGING CELL (2017)
Mast cells in neuroinflammation and brain disorders
Erik Hendriksen et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2017)
ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
Dmitry Petrov et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Evidence for mast cells contributing to neuromuscular pathology in an inherited model of ALS
Emiliano Trias et al.
JCI INSIGHT (2017)
Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease
Cheng Zhang et al.
ALZHEIMERS & DEMENTIA (2016)
Post-paralysis tyrosine kinase inhibition with masitinib abrogates neuroinflammation and slows disease progression in inherited amyotrophic lateral sclerosis
Emiliano Trias et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Masitinib for the treatment of mild to moderate Alzheimer's disease
Jaume Folch et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Hemichannels Are Required for Amyloid β-Peptide-Induced Degranulation and Are Activated in Brain Mast Cells of APPswe/PS1dE9 Mice
Paloma A. Harcha et al.
JOURNAL OF NEUROSCIENCE (2015)
Masitinib for the treatment of mild to moderate Alzheimer's disease
Jaume Folch et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2015)
Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study
Patrick Vermersch et al.
BMC NEUROLOGY (2012)
Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial
Francois Piette et al.
ALZHEIMERS RESEARCH & THERAPY (2011)
Masitinib (AB1010), a Potent and Selective Tyrosine Kinase Inhibitor Targeting KIT
Patrice Dubreuil et al.
PLOS ONE (2009)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Potentiation by histamine of synaptically mediated excitotoxicity in cultured hippocampal neurones: a possible role for mast cells
SD Skaper et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Share Paper
